Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Ho

Showing results (101-110 of 377) with videos related to

Pageof 38
Sort By:
Leukemia & Lymphoma|March 17, 2016
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatmentMark-Alexander Schwarzbich, Tilman Schöning, Martin Cremer, et al.
Psychosomatic Medicine|June 9, 2004
Psychiatric comorbidity and work disability in patients with inflammatory rheumatic diseasesBernd Löwe, Levke Willand, Wolfgang Eich, et al.
Annals of Hematology|June 18, 2017
In Burkitt lymphoma patients who relapse after induction with a short-intensive chemoimmunotherapy protocol, aggressive salvage chemotherapy therapy is ineffective: a single-center retrospective studyMartin Cremer, Mark-Alexander Schwarzbich, Tilman Schöning, et al.
Stem Cells (Dayton, Ohio)|November 18, 2006
Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanismSandra Gottschling, Rainer Saffrich, Anja Seckinger, et al.
Cytotherapy|October 15, 2013
Functional potentials of human hematopoietic progenitor cells are maintained by mesenchymal stromal cells and not impaired by plerixaforAnnette Ludwig, Rainer Saffrich, Volker Eckstein, et al.
Cytotherapy|December 14, 2011
Population dynamics of mesenchymal stromal cells during culture expansionAnne Schellenberg, Thomas Stiehl, Patrick Horn, et al.
Cells, Tissues, Organs|December 28, 2007
Adhesion of human hematopoietic progenitor cells to mesenchymal stromal cells involves CD44Wolfgang Wagner, Frederik Wein, Christoph Roderburg, et al.
Scientific Reports|February 1, 2018
Dynamic cellular phynotyping defines specific mobilization mechanisms of human hematopoietic stem and progenitor cells induced by SDF1α versus synthetic agentsCornelia Monzel, Alexandra S Becker, Rainer Saffrich, et al.
Cancer Chemotherapy and Pharmacology|July 21, 2014
In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemiaAleksandar Radujkovic, Thomas Luft, Peter Dreger, et al.
Blood|February 18, 2016
Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibitionMarc S Raab, Nicola Lehners, Jing Xu, et al.
Pageof 38

Showing results (101-110 of 377) with videos related to

Sort By:
Pageof 38
Leukemia & Lymphoma|March 17, 2016
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatmentMark-Alexander Schwarzbich, Tilman Schöning, Martin Cremer, et al.
Psychosomatic Medicine|June 9, 2004
Psychiatric comorbidity and work disability in patients with inflammatory rheumatic diseasesBernd Löwe, Levke Willand, Wolfgang Eich, et al.
Annals of Hematology|June 18, 2017
In Burkitt lymphoma patients who relapse after induction with a short-intensive chemoimmunotherapy protocol, aggressive salvage chemotherapy therapy is ineffective: a single-center retrospective studyMartin Cremer, Mark-Alexander Schwarzbich, Tilman Schöning, et al.
Stem Cells (Dayton, Ohio)|November 18, 2006
Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanismSandra Gottschling, Rainer Saffrich, Anja Seckinger, et al.
Cytotherapy|October 15, 2013
Functional potentials of human hematopoietic progenitor cells are maintained by mesenchymal stromal cells and not impaired by plerixaforAnnette Ludwig, Rainer Saffrich, Volker Eckstein, et al.
Cytotherapy|December 14, 2011
Population dynamics of mesenchymal stromal cells during culture expansionAnne Schellenberg, Thomas Stiehl, Patrick Horn, et al.
Cells, Tissues, Organs|December 28, 2007
Adhesion of human hematopoietic progenitor cells to mesenchymal stromal cells involves CD44Wolfgang Wagner, Frederik Wein, Christoph Roderburg, et al.
Scientific Reports|February 1, 2018
Dynamic cellular phynotyping defines specific mobilization mechanisms of human hematopoietic stem and progenitor cells induced by SDF1α versus synthetic agentsCornelia Monzel, Alexandra S Becker, Rainer Saffrich, et al.
Cancer Chemotherapy and Pharmacology|July 21, 2014
In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemiaAleksandar Radujkovic, Thomas Luft, Peter Dreger, et al.
Blood|February 18, 2016
Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibitionMarc S Raab, Nicola Lehners, Jing Xu, et al.
Pageof 38